Atlas Trials

Trial of TG4023 Combined With Flucytosine in Liver Tumors

Clinical trial NCT00978107 · COMPLETED

Trial details

NCT number
NCT00978107
Sponsor
Transgene
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hepatocellular Carcinoma
Start date
2009-09-01
Primary completion
2011-09-01
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.